Rearrangements of TP63, including TP63 fusions, are frequently described in several types of T-cell lymphoma, where they operate oncogenically via the generation of a truncated factor [13,14,15]. This evidence concerns the gene TP63 and T-cell non-Hodgkin lymphoma.